What Pharma Tech Industries does

Pharma Tech Industries (PTI) is a privately held pharmaceutical contract development and manufacturing organization (CDMO) specializing in non-sterile dry powder products. Founded in 1972 and headquartered in Royston, Georgia, the company operates through two wholly-owned entities—PTI Georgia, LLC (Royston, GA) and PTI Missouri, LLC (Union, MO)—providing combined cGMP-compliant production space exceeding 450,000 square feet. It targets three segments: prescription pharmaceutical manufacturers, OTC drug and personal care brands, and nutritional health/medical foods producers. The customer roster includes Johnson & Johnson, Bayer, Sanofi, Haleon, Coloplast, and other large multinationals, with six of the top ten global pharmaceutical corporations on the customer list and an average customer tenure exceeding ten years.

The technical platform centers on powder-handling expertise—complex blending, granulation, precision dry blending, and containment processing in ISO 7 and ISO 8 clean rooms with humidity-controlled suites maintained below 30% relative humidity. Capabilities span formulation development, process engineering and scale-up, commercial manufacturing, GMP analytical and microbiology testing, and packaging across sachets, stick packs (up to 400 pouches/minute), bottles, zippered pouches, bulk packs, effervescent tablets (~3 billion units/year), capsules (Planeta fillers up to 12,000 capsules/hour), tablets, bilayer tablets, and drug-device combinations such as heat-stable auto-injectors and breath-powered nasal delivery systems. Vertical integration includes in-house bottle manufacturing and component injection molding.

Revenue is generated through multi-year contract manufacturing agreements and per-batch production engagements with enterprise pharmaceutical and consumer health customers, via direct sales led by Business Development Representatives and regional sales contacts. Pricing is custom and quote-based. Marketing relies on content (executive-authored blog), industry event participation (AAPS PharmSci 360, SupplySide Global), case studies, and inbound consultation. Leadership includes CEO Darrin T. Schellin (appointed 2024, previously CEO of GBI Bio), Chairman Tee Noland, and recent addition Sam Ricchezza as Senior Managing Advisor, Commercial Operations.

Name

Pharma Tech Industries

Legal name

Pharma Tech Industries

Website

https://pharma-tech.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

251–500 employees

Short description

Pharma Tech Industries is a privately held U.S. CDMO specializing in non-sterile dry powder blending, formulation, and high-speed packaging for pharmaceutical, OTC, and nutritional customers, serving six of the top ten global pharmaceutical corporations from cGMP facilities in Georgia and Missouri.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Pharmaceutical contract manufacturing
• Powder blending services
• CDMO services
• Effervescent tablet manufacturing
• Contract packaging

Headquarters

HQ city

Athens

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Contract Manufacturing Services: Pharma Tech Industries operates as a CDMO (Contract Development and Manufacturing Organization) providing development and manufacturing services for pharmaceutical, OTC, personal care, and nutritional products. Revenue is generated through long-term manufacturing agreements and per-batch production contracts, with services spanning formulation, production, and packaging.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pharma Tech Industries is a pharmaceutical contract development and manufacturing organization (CDMO) specializing exclusively in non-sterile dry powder products for pharmaceutical, OTC/personal care, and nutritional/health/medical food brand owners. It offers vertically integrated services spanning formulation development, process engineering, cGMP commercial-scale manufacturing, and high-speed packaging in formats such as sachets, stick packs, bottles, jars, zippered pouches, bulk packs, effervescent tablets, capsules, bilayer tablets, and drug-device combinations, supported by in-house GMP analytical and microbiology labs with full serialization and traceability.

Product overview

Pharma Tech Industries is a Contract Development and Manufacturing Organization (CDMO) offering a full-service integrated platform for powder-based pharmaceutical, OTC, and nutraceutical products. The portfolio centers on non-sterile dry powder blending and high-speed packaging capabilities, spanning formulation development through high-volume commercial-scale production. The company's core product offerings include multiple packaging formats (sachets, stick packs, bottles, zippered pouches, bulk packs), dosage forms (effervescent tablets, capsules, tablets, drug-device combinations), and drug delivery technologies (nasal delivery systems, auto-injectors). These are supported by integrated services including GMP analytical/microbiology labs, serialization and traceability, process engineering, and formulation development. The company operates FDA-registered, NSF-compliant cGMP facilities in Georgia and Missouri totaling over 450,000 square feet.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Contract Manufacturing (CDMO Services) Full-service non-sterile dry powder contract development and manufacturing for pharmaceutical, OTC, personal care, and nutritional/health/medical food brand owners, spanning formulation development, process engineering, cGMP commercial-scale manufacturing, and high-speed packaging.
• Effervescent Products Effervescent tablets and dosage formats manufactured in dedicated low-humidity suites, with annual capacity of approximately 3 billion effervescent tablets.
• Capsules Capsule filling services including micro-dosing using Planeta Capsule Fillers capable of speeds up to 12,000 capsules per hour.
• Tablets and Bilayer Tablets Tableting and bilayer tableting capabilities for oral solid dosage pharmaceutical products.
• Sachets Unit-dose foil sachets with printed dosage information for precise powder packaging in multiple sizes (0.5g, 1.0g, and 5g) for clinical trials and commercial products.
• Stick Packs Elongated tube-style single-serve packaging sealed on three sides, offering precise dosing, portability, and sustainability benefits for powders. High-speed stick pack lines capable of producing up to 400 pouches per minute, with widths from 0.454 to 2 inches and tooling modifications for widths up to 4 inches and lengths up to 12 inches.
• Bottles and Jars Multi-dose powder packaging with bottle and cap manufacturing capabilities, suitable for consumer health and pharmaceutical products.
• Zippered Pouches Gusseted multi-serving pouches for powder products requiring larger format packaging with convenient resealable closure.
• Bulk Packs Large-volume powder packaging for products requiring multi-dose institutional or commercial bulk formats.
• Drug-Device Combinations Complex pharmaceutical products combining drug substances with medical devices, including auto-injectors and nasal delivery systems, with capabilities in device assembly and packaging.
• Nasal Delivery Systems Breath-powered nasal delivery systems for sumatriptan-based migraine medications, including capsule filling, device assembly, and packaging for NDA submission.
• Heat-Stable Auto-Injectors Dual-chamber auto-injectors for heat-stable epinephrine using wet/dry powder-liquid mixing technology to enhance temperature resilience and extend shelf life.
• Medical Swabs Specialty medical device products for diagnostic and pharmaceutical applications.
• Formulation Development Services Custom formulation development including taste masking, dissolution optimization, and stability enhancement for powder-based pharmaceutical and nutraceutical products.
• Process Engineering Technical transfer, scale-up, and process optimization services ensuring efficient transition from development through commercialization.
• GMP Analytical and Microbiology Labs In-house qualified and staffed analytical laboratories supporting method transfer, development, qualification, and cGMP clinical and commercial release testing.
• Serialization and Traceability Full product traceability and serialization capabilities ensuring regulatory compliance and supply chain visibility.
• Powder Blending and Containment Specialty filling and containment of powder-based pharmaceuticals with controlled humidity environments below 30% RH and clean air suites.

Named customers15 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Bora Pharmaceuticals: CDMO focused on oral solid dose manufacturing, including acquisitions of Emergent's CDMO business. Directly comparable to PTI as a powder/tablet specialist serving major pharma; PTI's own senior advisor previously held a President role at Bora.
• Catalent: One of the largest global CDMOs offering oral solid dose, softgel, sterile, and biologic services. Highly comparable to PTI in commercial-scale oral solid dose and packaging, though much larger and broader in scope.
• Aenova Group: European-headquartered CDMO with strong oral solid dose and effervescent tablet capabilities. Directly comparable to PTI on powder processing, effervescent production, and broad pharma customer base.
• Cambrex: CDMO specializing in small-molecule API and finished dosage forms, including complex oral solids. Highly relevant peer given overlapping small-molecule and drug product focus with PTI.
• Halo Pharma: CDMO specializing in oral solid dose, liquids, and creams for small-to-mid pharma. Comparable to PTI in oral solid dose commercial manufacturing and small-to-mid pharma customer base.
• Patheon (Thermo Fisher Scientific): Major pharma CDMO within Thermo Fisher's pharma services segment, offering small-molecule API and drug product manufacturing including oral solids. Directly comparable to PTI's small-molecule commercial powder manufacturing.

Emerging players

• Ascendia Pharmaceuticals: Smaller specialty CDMO focused on complex formulations including injectables and oral solids. Comparable as a niche commercial-scale CDMO targeting difficult-to-formulate molecules, overlapping with PTI's complex powder focus.
• Quotient Sciences: CDMO offering formulation development, clinical manufacturing, and commercial supply, including oral dose. Comparable in formulation-to-commercial integration, though heavier in clinical-stage work.

Broad incumbents

• Glatt Air Techniques / Glatt Group: Long-established powder processing technology and contract manufacturing group with effervescent and granulation expertise. Comparable to PTI on powder/granulation and effervescent manufacturing heritage.

Regional players

• Pfanstiehl (part of Bora): U.S.-based cGMP manufacturer of high-purity excipients, APIs, and injectables. Partially comparable to PTI as a U.S. cGMP powder/ingredient manufacturer, though more upstream and focused on biologics inputs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Tech Industries